CLINICAL_TRIALS ClinicalTrials.gov record update

Post-marketing Surveillance (PMS) of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) -16/18 Vaccine, Cervarix™ When Administered to Healthy Females According to the Prescribing Information in Sri Lanka

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01551537
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:26.552336+00:00
Published At: 2013-09-09T00:00:00+00:00
Record Updated At: 2013-09-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Human Papillomavirus Infection"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2013-09-09"
protocolSection.identificationModule.nctId: "NCT01551537"
protocolSection.identificationModule.officialTitle: "Post-marketing Surveillance (PMS) of GlaxoSmithKline (GSK) Biologicals\u0027 Human Papillomavirus (HPV) -16/18 Vaccine, Cervarix\u2122 When Administered to Healthy Females According to the Prescribing Information in Sri Lanka"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.